Mahalingam, Devalingam
Fountzilas, Christos
Moseley, Jennifer
Noronha, Nicole
Tran, Hue
Chakrabarty, Romit
Selvaggi, Giovanni
Coffey, Matthew
Thompson, Brad
Sarantopoulos, John
Funding for this research was provided by:
Oncolytics Biotech
Article History
Received: 18 November 2016
Accepted: 8 February 2017
First Online: 13 March 2017
Compliance with ethical standards
:
: This study was funded by Oncolytics Inc (study sponsor).
: Devalingam Mahalingam declares that he has no conflict of interest. Christos Fountzilas declares that he has no conflict of interest. Jennifer Moseley declares that she has no conflict of interest. John Sarantopoulos declares that he has no conflict of interest. Nicole Noronha, Hue Tran, Romit Chakrabarty, Matt Coffey, and Brad Thompson are employed by Oncolytics Biotech Inc., with stock options and/or stock. Giovanni Selvaggi was employed with Oncolytics Biotech Inc. during a portion of this study and manuscript preparation.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.